Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

PSTI Analysis & Videos »


PSTI: Bull or Bear?

Bullish on PSTI ... PSTI

62%

-25.00% in 251 days Pluristem Therapeutics, Inc., a bio-therapeutics company, engages in the production, research, and development of placental-derived adherent stromal cells (ASCs). The company also involves in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of various severe degenerative, ischemic, and autoimmune disorders. It develops a pipeline of products that are derived from the human placenta, a non-controversial, non-embryonic, adult stem cell source. These placental adherent stromal cells (ASCs) are expanded in the companyÂ’s proprietary PluriXTM three-d... Continue reading »

By  Marian Filo   (-24.55%  risk: aggressive)  03/18/09

Comment

Stem Cell Index Down 7% in Past Week PSTI

73%

-18.40% in 281 days Stem Cell Index Down 7% in Past Week <> By Mike Havrilla on 2/15/09 The table at my website link below includes 26 companies in the ETF Innovators Emerging Stem Cell Index, which lost 7% of its market value in the past week (at 1,148 today) and posted a 15.2% loss over the past year on an equal-weight basis. http://www.etfinnovators.com/2009/02/stem-cell-index-down-7-i... Results for benchmark indexes and ETFs include gains of 1.5% for the Cosmetic and Restorative Medicine Index and losses of 1.2% for SPDR S&P Biotech (XBI), 18.7% for Healthcare Sector... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  02/16/09

Comment

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) Is The Subway Pick Of The Day PSTI

70%

-45.88% in 85 days (closed on 12/10/08) Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) , a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announced today that Zami Aberman, President & CEO of the Company, will present at the bioLOGIC Europe 2008 conference on  Tuesday, September 16, 2008 at 11:15 a.m.  Central European Time at the Crowne Plaza Hotel, Geneva, Switzerland. The title of Mr. Aberman’s presentation is: “Challenges for small and medium biotechs in bringing biological c< /><>< />< />< /><>< />< /><>< />< />< />< />< />< />< />< /><><><>< />< /><>< />< />< />< />< />< />< /><><><>< />... Continue reading »

By  TheSUBWAY   (-0.57%  risk: conservative)  09/16/08

1 comment

PSTI Annouces Human Clincal Studies PSTI

33%

-6.44% in 1 day (closed on 09/11/08) <meta content="text/html; charset=utf-8" http-equiv="Content-Type" /> <meta name="ProgId" content="Word.Document" /> <meta name="Generator" content="Microsoft Word 12" /> <meta name="Originator" content="Microsoft Word 12" /> <link href="file:///C:\DOCUME~1\Ryan\LOCALS~1\Temp\msohtmlclip1\01\clip_filelist.xml" rel="File-List" /> <link href="file:///C:\DOCUME~1\Ryan\LOCALS~1\Temp\msohtmlclip1\01\clip_themedata.thmx" rel="themeData" /> <link href="file:///C:\DOCUME~1\Ryan\LOCALS~1\Temp\msohtmlclip1\01\clip_colorschememapping.xml" rel="colorSchemeMapping" /> <!--[if gte mso... Continue reading »

By  joka86   (-23.02%  risk: conservative)  09/10/08

Comment

Pluristem Therapeutics Inc. (Nasdaq: PSTI) is TheSUBWAY Stock Pick of the Day PSTI

70%

-2.91% in 9 hours (closed on 09/10/08) <> This morning we are featuring Pluristem Therapeutics Inc. (Nasdaq: PSTI).  Visit TheSUBWAY Blog Here: http://stock-promoter.thesubway.com/thesubway-clients/plurist... News for Pluristem Therapeutics Inc. (Nasdaq:PSTI), Full News can be read here: http://stock-promoter.thesubway.com/thesubway-clients/plurist... <> Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indicatio... Continue reading »

By  TheSUBWAY   (-0.57%  risk: conservative)  09/10/08

3 comments

Permanent Link to TheSubway Pre-Market Alert: NASDAQ:PSTI - AASI - Watch For Early Buying Opportunities! PSTI

70%

-6.67% in 1 day (closed on 08/12/08) TheSUBWAY.com - Pre-Market Alerts - PSTI - AASI Pluristem Therapeutics, Inc (NASDAQ: PSTI) - Pluristem’s PLX-MS Shows Potential Benefit in the Prevention of Multiple Sclerosis AASI - All Asia Licensing, Inc. (Pink Sheets: AASI) - Announces Proposed Joint Venture with Bio Research Firm for Bovine Testing, Beef Grading ! <> <!--[if supportFields]> DATE \@ "MMMM d, yyyy" < ![endif]--> August 11, 2008 <!--[if supportFields]> < ![endif]--> - TheSUBWAY: Announces the following stocks to its Pre Market Standouts List: All Asia Licensing, Inc. (Pink Sheets: AA... Continue reading »

By  TheSUBWAY   (-0.57%  risk: conservative)  08/11/08

Comment

Pluristem Therapeutics Announces $1.6 Million Securities Offering PSTI

70%

+3.46% in 4 days (closed on 08/11/08) <> Pluristem Therapeutics Inc. ( Nasdaq:PSTI ) (DAX:PJT) , a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced it has entered into definitive agreements to sell common stock and warrants to selected institutional investors for aggregate gross proceeds of $1,600,000. The offering is made pursuant to the Form S-3 shelf registration statement that was filed by Pluristem with the Securities and Exchange Commission (the “SEC”) and declared ef<><><><><><><><><><><><><><><><><>< /><>< /><><><><><><><><><><>< /><><>< /><><>< /><><>< /><><>< /><><><><>< /><><>< /><><>< />... Continue reading »

By  TheSUBWAY   (-0.57%  risk: conservative)  08/07/08

Comment

People Bullish on PSTI

Marian Filo Principal 62% 8 mos ago	Mike Havrilla Principal 73% 9 mos ago	efarahmd Analyst 54% about 1 year ago
3dsight Analyst 66% about 1 year ago

People Bearish on PSTI

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.